Document Detail


A newly designed anticancer tumor immunity drug delivery system.
MedLine Citation:
PMID:  1751099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors used a fibrin clot (FC) as a carrier of an anti-cancer drug (AD) to achieve sustained release of the drug. Adriamycin (ADM) and cis-platinum (CDDP) were individually encapsulated into an FC, and the profile of release of each AD from the FC-AD was examined in vitro. The FC-AD was placed intra-abdominally in ascites hepatoma AH130-bearing rats, and ADM or CDDP solution was intraperitoneally injected (IP) into other cancer bearing rats. The survival time was recorded, and related oncolytic mechanisms were investigated. The release of AD from the FC continued for over 15 days. Sixty-eight percent of the rats treated with FC-AD survived for more than 200 days and evidence of malignancy disappeared. Almost all of the IP rats and non-treated rats died within 20 days; these animals had massive ascites and extensive metastases. Immunologic studies confirmed that various tumor immunoresponses were induced in the rats treated with FC-AD. The FC-AD system warrants further study for possible antineoplastic activities in vivo.
Authors:
A Sugitachi; T Shindo; Y Matsuda; I Sakamoto
Related Documents :
171059 - Interaction of normal and tumor transfer rna methyltransferases with ethionine-induced ...
11117319 - A kinetic estimate of the free aldehyde content of aldoses.
2628429 - Biosynthesis of nonspecific lipid transfer protein (sterol carrier protein 2) on free p...
6158979 - Comparison of synthesis and secretion of plasma albumin, fibrinogen and alpha 2-macrogl...
3033849 - Polybrominated dibenzo-p-dioxins and related compounds: quantitative in vivo and in vit...
7324699 - Catabolism of desialylated glycoproteins during carcinogenesis and inflammation in rats.
17599359 - Prostaglandin e1 improves survival rate after 95% hepatectomy in rats.
272289 - Measurement of erythropoietin in chloroleukemic rats.
6331169 - Auricular chondritis in fawn-hooded rats. a spontaneous disorder resembling that induce...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  ASAIO transactions / American Society for Artificial Internal Organs     Volume:  37     ISSN:  0889-7190     ISO Abbreviation:  ASAIO Trans     Publication Date:    1991 Jul-Sep
Date Detail:
Created Date:  1992-01-29     Completed Date:  1992-01-29     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  8611947     Medline TA:  ASAIO Trans     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  M177-8     Citation Subset:  IM    
Affiliation:
Department of Surgery, Osaka National Hospital, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / administration & dosage*
Cell Line
Cisplatin / administration & dosage
Delayed-Action Preparations
Doxorubicin / administration & dosage
Drug Carriers*
Fibrin*
Liver Neoplasms, Experimental / drug therapy
Male
Neoplasm Transplantation
Rats
Rats, Inbred Strains
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Delayed-Action Preparations; 0/Drug Carriers; 15663-27-1/Cisplatin; 23214-92-8/Doxorubicin; 9001-31-4/Fibrin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improved biocompatibility of bovine pericardium using a new method of cross linking.
Next Document:  Application of finite element analysis for assessing biocompatibility of intra-arterial catheters an...